Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study

AIMS: Our study aimed to evaluate the impacts of the cytochrome P450 (CYP) 2B6‐G516T and CYP2D6 genetic polymorphisms on pharmacokinetic and clinical parameters in patients receiving methadone maintenance treatment. METHODS: Opioid PhArmacoLogy (OPAL) was a clinical survey of the sociodemographic ch...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Clin Pharmacol
Autors principals: Victorri‐Vigneau, Caroline, Verstuyft, Céline, Bouquié, Régis, Laforgue, Edouard‐Jules, Hardouin, Jean‐Benoit, Leboucher, Juliette, Le Geay, Bertrand, Dano, Corine, Challet‐Bouju, Gaëlle, Grall‐Bronnec, Marie
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6595468/
https://ncbi.nlm.nih.gov/pubmed/30907440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13936
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars